Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib
暂无分享,去创建一个
A. Zelenetz | S. O'brien | Jennifer R. Brown | T. Robak | M. Montillo | A. Mato | R. Furman | P. Hillmen | N. Lamanna | R. Dubowy | V. Munugalavadla | L. Gu